Market Size of Global Bovine-based Collagen for Biomedical Applications Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 1.17 Billion |
Market Size (2029) | USD 1.89 Billion |
CAGR (2024 - 2029) | 10.16 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Bovine-Based Collagen For Biomedical Applications Market Analysis
The Global Bovine-based Collagen for Biomedical Applications Market size is estimated at USD 1.17 billion in 2024, and is expected to reach USD 1.89 billion by 2029, growing at a CAGR of 10.16% during the forecast period (2024-2029).
COVID-19 had a profound impact on the studied market owing to the cancellations of elective procedures and supply chain disruptions. The market declined in the initial phase of the pandemic. However, the research studies regarding the use of bovine-based collagen in treating COVID-19 and the advantages of the same compensated for the market growth in the later phase. For instance, according to an article published in October 2021, lactoferrin is a natural supplement with antiviral qualities that could be utilized as an adjuvant for COVID-19 and other respiratory tract infections. A protein called lactoferrin is naturally present in breast milk and other fluids in the stomach, nose, eyes, and respiratory tract. It is also present in cow and human milk. Because of its antiviral properties, lactoferrin can be used as a supplement in addition to other medications to treat COVID-19 and other respiratory infections. The studied market is expected to achieve a stable growth rate gradually in the upcoming years, owing to the rising tendency of people toward a healthy lifestyle and the increased demand for functional ingredients such as collagen peptides.
In addition, growing demand for bovine-based collagen to treat various diseases, increasing demand for dental and orthopedic surgeries, and ongoing R&D for the development of wound healing and regenerative medicines are actively affecting the growth of the studied market.
The major factor attributing to the growth of the market is the increasing demand for bovine-based collagen in biomedical applications to treat various medical conditions like arthritis and osteoporosis and to improve skin health. According to the CDC's October 2021 update, about 58.5 million adults in the United States that is 23.7%, or 1 in 4, have arthritis by medical diagnosis. Women are more likely than men to have arthritis which is 23.5% more than men by 18.1%. It is predicted that 78.4 million adults are expected to have the condition by 2040. Similarly, as per an article published in the Journal of Orthopaedic Surgery and Research in October 2021, osteoporosis is a common disease all over the world. The prevalence of osteoporosis in women in the world was reported to be 23.1% and while the prevalence of osteoporosis among men in the world was found to be 11.7%. Thus, the high burden of osteoporosis and arthritis boosts the demand for bovine collagen for treatment purposes, which drives the market growth over the forecast period.
Furthermore, the increasing demand for dental and orthopedic surgeries for reconstruction and the rise in research and development of wound healing and regenerative medicines are boosting the market growth. For instance, according to an article published in Basel Journal in November 2021, supplemental collagen from several sources, including porcine, bovine, and marine collagen, can enhance skin integrity and slow the aging process. They work well to reduce wrinkles, rejuvenate the skin, and reverse skin aging. In recent years, oral collagen supplements have gained a lot of popularity. Researchers looked at how oral collagen supplementation affected the dermal collagen network and the hydration of the skin. Thus, the research and development studies carried out on bovine collagen for biomedical applications are expected to accelerate the market in the forecast period.
Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period. However, the high risk of disease transmission is likely to impede market growth.
Bovine-Based Collagen For Biomedical Applications Industry Segmentation
As per the scope of the report, bovine collagen is the type of protein abundantly present in the connective tissue, bones, and cartilage of cows. It is used widely in biomedical applications such as cosmetic surgery, reconstructive surgery, cardiology, and scientific study. The Bovine-based Collagen for Biomedical Applications Market is Segmented by Application (Bone Graft Substitutes, Collagen-based Scaffolds, Hemostats, Skin Substitutes, Cartilage Repairs, and Others) and Geography (North America, Europe, Asia-Pacific, and the Rest of the World). The report offers the value (in USD million) for the above segments.
By Application | |
Bone Graft Substitutes | |
Collagen-based Scaffolds | |
Hemostats | |
Skin Substitutes | |
Cartilage Repairs | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
Rest of the World |
Global Bovine-based Collagen for Biomedical Applications Market Size Summary
The bovine-based collagen market for biomedical applications is poised for significant growth over the forecast period, driven by increasing demand for its use in treating various medical conditions and enhancing skin health. The market experienced initial setbacks due to the COVID-19 pandemic, which disrupted supply chains and led to the cancellation of elective procedures. However, the later phases saw a rebound as research highlighted the potential of bovine collagen in COVID-19 treatment, leveraging its antiviral properties. The rising interest in healthy lifestyles and functional ingredients like collagen peptides further supports market expansion. The demand for bovine-based collagen is bolstered by its applications in dental and orthopedic surgeries, as well as ongoing research in wound healing and regenerative medicine, which are critical for addressing conditions such as arthritis and osteoporosis.
North America is expected to maintain a significant market share, attributed to the high prevalence of bone-related disorders, an aging population, and robust healthcare infrastructure. The region's market growth is also fueled by the increasing incidence of chronic and diabetic wounds, which necessitate advanced wound healing solutions. The competitive landscape of the market features several key players, including BBI Solutions, Symatese, and Rousselot, who are actively involved in product innovation and expansion. Recent developments, such as the launch of youth-enhancing supplements and advancements in cell-cultured collagen production, underscore the dynamic nature of the market. These factors collectively indicate a promising growth trajectory for the bovine-based collagen market in biomedical applications.
Global Bovine-based Collagen for Biomedical Applications Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Demand for Bovine-Based Collagen to Treat Various Disease
-
1.2.2 Increasing demand for Dental, and Orthopedic Surgeries
-
1.2.3 Ongoing R&D for the Development of Wound Healing & Regenerative Medicines
-
-
1.3 Market Restraints
-
1.3.1 High Risk of Disease Transmission
-
-
1.4 Porter Five Forces
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Application
-
2.1.1 Bone Graft Substitutes
-
2.1.2 Collagen-based Scaffolds
-
2.1.3 Hemostats
-
2.1.4 Skin Substitutes
-
2.1.5 Cartilage Repairs
-
2.1.6 Others
-
-
2.2 Geography
-
2.2.1 North America
-
2.2.1.1 United States
-
2.2.1.2 Canada
-
2.2.1.3 Mexico
-
-
2.2.2 Europe
-
2.2.2.1 Germany
-
2.2.2.2 United Kingdom
-
2.2.2.3 France
-
2.2.2.4 Italy
-
2.2.2.5 Spain
-
2.2.2.6 Rest of Europe
-
-
2.2.3 Asia-Pacific
-
2.2.3.1 China
-
2.2.3.2 Japan
-
2.2.3.3 India
-
2.2.3.4 Australia
-
2.2.3.5 South Korea
-
2.2.3.6 Rest of Asia-Pacific
-
-
2.2.4 Rest of the World
-
-
Global Bovine-based Collagen for Biomedical Applications Market Size FAQs
How big is the Global Bovine-based Collagen for Biomedical Applications Market?
The Global Bovine-based Collagen for Biomedical Applications Market size is expected to reach USD 1.17 billion in 2024 and grow at a CAGR of 10.16% to reach USD 1.89 billion by 2029.
What is the current Global Bovine-based Collagen for Biomedical Applications Market size?
In 2024, the Global Bovine-based Collagen for Biomedical Applications Market size is expected to reach USD 1.17 billion.